<DOC>
	<DOCNO>NCT01938521</DOCNO>
	<brief_summary>The aim study examine whether chronic administration 12 week polyphenols contain Red Grape Cells ( RGC ) powder effect mRNA expression SIRT1 Clock Genes , circulate level HbA1c , lipid , blood pressure postprandial response glucose , lipid , insulin , C-peptide GLP-1 patient type 2 diabetes .</brief_summary>
	<brief_title>Effects Red Grape Cells ( RGC ) Powder Type 2 Diabetics</brief_title>
	<detailed_description>There grow body evidence demonstrate polyphenols specially investigate Resveratrol contain Red Grape Cells ( RGC ) exert beneficial effect several marker metabolic syndrome i.e . antioxidant , anti-inflammatory , anti-atherosclerotic , vasodilator antihypertensive activity . Many beneficial metabolic effect polyphenols , occur via activation sirtuin-1 silent information regulator-1 gene ( SIRT1 ) . This gene express adipose tissue , muscle , endothelium , peripheral blood cell , etc play pivotal role regulation Circadian Clock Genes ( CCG ) involve glucose lipid metabolism , endothelial function , etc . By activation SIRT1 CCG polyphenols , may influence circadian secretion adiponectin , insulin , asymmetric dimethylarginine ( ADMA ) hormones influence insulin sensitivity , muscular glucose uptake , NO synthesis , nocturnal hepatic glucose production , lipolisis endothelial function It show several study animal clinical study subject metabolic syndrome SIRT1 expression regulation CCG , improve insulin sensitivity skeletal muscle , prevent weight gain ; improve pancreatic beta-cell function enhance insulin secretion glucose tolerance . It associate increased lipolisis white adipose tissue , decrease glycolysis , increase fatty acid oxidation skeletal muscle increase Nitric Oxide endothelium . Given polyphenols directly clock gene enhance SIRT1 expression appear counter effect high-fat diet , obesity metabolic syndrome , protect insulin resistance , hyperglycemia , dyslipidemia endothelial dysfunction . It rise possibility polyphenols contain Red Grape Cells ( RGC ) activation SIRT1 may also exert beneficial effect subject affect type 2 diabetes</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Type 2 diabetes patient 2 . HbA1C &gt; 7 % 3 . Duration diabetes : 0.5 20 year 4 . Subjects ≥ 30 ≤70 year age 5 . BMI : 22 35 kg/m2 6 . Fasting Triglyceride serum level ≥ 150 mg/dl 7 . All oral antidiabetic treatment allow , exception thiazolidinediones ( glitazones ) .i.e . pioglitazone ( Actos ) rosiglitazone ( Avandia ) . Insulin GLP1 analog allow . 8 . Normal liver kidney function 9 . Normal thyroid function 10 . Acceptable health beside diabetes base interview , medical history , physical examination , laboratory test 11 . Willingness avoid use overthecounter medication , herb , supplement throughout entire study . 12 . Willingness avoid ingestion food contain peanut , bilberry , blueberry , cranberry , strawberry , raspberry , grape , grape juice , cocoa powder , dark chocolate , red wine throughout entire study 13 . Stable physical activity pattern three month immediately precede study 14 . Usually wake 06:00 07:00 go sleep 22:00 24:00 . 15 . No shift work within 5 year study 16 . Did cross time zone within 1 month study 17 . Read understood informed consent form sign voluntarily 1 . Type 1 diabetes 2 . Clinically significant pulmonary , cardiac , renal , hepatic , neurologic , psychiatric , infectious , malignant disease 3 . Abnormal liver function test define increase factor least 2 upper normal limit alanine aminotransferase ( ALT ) and/or aspartate aminotransferase ( AST ) 4 . Pregnancy lactation 5 . Illicit drug abuse alcoholism 6 . Treatment thiazolidinediones ( glitazones ) .i.e . pioglitazone ( Actos ) rosiglitazone ( Avandia ) . 7 . Insulin GLP1 analog allow . 8 . Anti hyperlipidemic treatment fibrates . Statins allow 9 . Subjects take anoretic drug month immediately prior study 10 . Subjects steroid treatment 11 . Those major illness , liver , heart , kidney , lung , infectious , neurological , psychiatric , immunological neoplastic disease , 12 . Those eat disorder 13 . Known hypersensitivity grape , soy and/or casein 14 . Subjects bariatric surgery , exclude</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Red Grape Cells powder ( RGC )</keyword>
	<keyword>Placebo ( PLA )</keyword>
</DOC>